-
31دورية أكاديمية
المؤلفون: Haugh, Alexandra M., Daud, Adil I.
المصدر: The Cancer Journal ; volume 30, issue 2, page 108-112 ; ISSN 1540-336X 1528-9117
-
32دورية أكاديمية
المؤلفون: Wong, Paul, Wisneski, Andrew D., Tsai, Katy K., Chang, Tammy T., Hirose, Kenzo, Nakakura, Eric K., Daud, Adil I., Maker, Ajay V., Corvera, Carlos U.
المصدر: World Journal of Surgical Oncology; 3/11/2024, Vol. 22 Issue 1, p1-6, 6p
مصطلحات موضوعية: SMALL intestine, METASTASECTOMY, LENGTH of stay in hospitals, METASTASIS, MELANOMA, OVERALL survival, INTESTINAL diseases
-
33دورية أكاديمية
المؤلفون: Tsai, Katy K, Daud, Adil I
المصدر: Journal of Hematology & Oncology. 8(1)
مصطلحات موضوعية: Immunization, Cancer, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Clinical Trials, Phase III as Topic, Disease-Free Survival, Double-Blind Method, Drug Administration Schedule, Follow-Up Studies, Humans, Ipilimumab, Melanoma, Multicenter Studies as Topic, Nivolumab, Randomized Controlled Trials as Topic, Skin Neoplasms, Treatment Outcome, Immunotherapy, PD-1, CTLA-4, Cardiorespiratory Medicine and Haematology, Oncology and Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/18s7b110Test
-
34دورية أكاديمية
المؤلفون: Tsai, Katy K, Zarzoso, Inés, Daud, Adil I
المصدر: Human Vaccines & Immunotherapeutics. 10(11)
مصطلحات موضوعية: Cancer, Immunization, Climate-Related Exposures and Conditions, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, B7-H1 Antigen, CTLA-4 Antigen, Humans, Immunotherapy, Lymphocyte Activation, Melanoma, Nivolumab, Programmed Cell Death 1 Receptor, T-Lymphocytes, BMS-936559, PD-1, PD-L1, PD-L2, immunotherapy, MPDL3280A, melanoma, nivolumab, pembrolizumab, AE, adverse event, APC, antigen presenting cell, ASCO, American Society of Clinical Oncology, CTLA-4, cytotoxic T-lymphocyte-associated protein 4, FDA, Food and Drug Administration, gp100, glycoprotein 100 vaccine, Ig, immunoglobulin, ITIM, immunoreceptor tyrosine-based inhibitory motif, ITSM, immunoreceptor tyrosine-based switch motif, MAPK, mitogen-activated protein kinase, MHC, major histocompatibility complex, NK, natural killer, ORR, objective response rate, OS, overall survival, PD, progressive disease, programmed cell death 1, programmed cell death ligand 1, PFS, progression free survival, TCR, T cell receptor, TIL, tumor infiltrating lymphocyte, AE, adverse event, APC, antigen presenting cell, ASCO, American Society of Clinical Oncology, CTLA-4, cytotoxic T-lymphocyte-associated protein 4, FDA, Food and Drug Administration, ITIM, immunoreceptor tyrosine-based inhibitory motif, ITSM, immunoreceptor tyrosine-based switch motif, Ig, immunoglobulin, MAPK, mitogen-activated protein kinase, MHC, major histocompatibility complex, NK, natural killer, ORR, objective response rate, OS, overall survival, PD, progressive disease, PD-1, programmed cell death 1, PD-L1, programmed cell death ligand 1, PFS, progression free survival, TCR, T cell receptor, TIL, tumor infiltrating lymphocyte, gp100, glycoprotein 100 vaccine, Immunology, Medical Microbiology, Pharmacology and Pharmaceutical Sciences, Virology
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/49q8w2djTest
-
35دورية أكاديمية
المؤلفون: Huppert, Laura A., Green, Michael D., Kim, Luke, Chow, Christine, Leyfman, Yan, Daud, Adil I., Lee, James C.
المساهمون: Parker Institute for Cancer Immunotherapy
المصدر: Cellular & Molecular Immunology ; volume 19, issue 1, page 33-45 ; ISSN 1672-7681 2042-0226
مصطلحات موضوعية: Infectious Diseases, Immunology, Immunology and Allergy
الإتاحة: https://doi.org/10.1038/s41423-021-00742-4Test
https://www.nature.com/articles/s41423-021-00742-4.pdfTest
https://www.nature.com/articles/s41423-021-00742-4Test -
36دورية أكاديمية
المؤلفون: Posch, Christian, Moslehi, Homayoun, Feeney, Luzviminda, Green, Gary A, Ebaee, Anoosheh, Feichtenschlager, Valentin, Chong, Kim, Peng, Lily, Dimon, Michelle T, Phillips, Thomas, Daud, Adil I, McCalmont, Timothy H, LeBoit, Philip E, Ortiz-Urda, Susana
المصدر: Proceedings of the National Academy of Sciences of the United States of America. 110(10)
مصطلحات موضوعية: Biochemistry and Cell Biology, Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Biological Sciences, Pediatric, Rare Diseases, Genetics, Cancer, Animals, Antineoplastic Agents, Apoptosis, Cell Line, Tumor, Drug Synergism, Female, GTP Phosphohydrolases, Humans, MAP Kinase Signaling System, Melanoma, Membrane Proteins, Mice, Mice, Nude, Mutation, Phosphoinositide-3 Kinase Inhibitors, Protein Kinase Inhibitors, Signal Transduction, TOR Serine-Threonine Kinases, Xenograft Model Antitumor Assays
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/7166h7qqTest
-
37دورية أكاديمية
المؤلفون: Algazi, Alain P, Soon, Christopher W, Daud, Adil I
المصدر: Cancer management and research. 2(1)
مصطلحات موضوعية: chemotherapy, clinical trials, immune modulation, melanoma, resection, small molecule kinase inhibitors, Oncology and Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/2rh3q355Test
-
38دورية أكاديمية
المؤلفون: Robert, Caroline, Carlino, Matteo S., McNeil, Catriona, Ribas, Antoni, Grob, Jean-Jacques, Schachter, Jacob, Nyakas, Marta, Kee, Damien, Petrella, Teresa M., Blaustein, Arnold, Lotem, Michal, Arance, Ana, Daud, Adil I., Hamid, Omid, Larkin, James, Anderson, James, Krepler, Clemens, Grebennik, Dmitri, Long, Georgina V.
المصدر: Journal of Clinical Oncology; 8/20/2023, Vol. 41 Issue 24, p3998-4003, 11p
-
39دورية أكاديمية
المؤلفون: Rasco, Drew W., Medina, Theresa, Corrie, Pippa, Pavlick, Anna C., Middleton, Mark R., Lorigan, Paul, Hebert, Chris, Plummer, Ruth, Larkin, James, Agarwala, Sanjiv S., Daud, Adil I., Qiu, Jiaheng, Bozon, Viviana, Kneissl, Michelle, Barry, Elly, Olszanski, Anthony J.
مصطلحات موضوعية: Phase 1, Pan-RAF inhibitor, Melanoma, BRAF, Tovorafenib
وصف الملف: application/pdf; application/zip; text/xml
-
40كتاب
المؤلفون: Chow, Melissa, Sangalang, Elizabeth A., Chow, Christine, Daud, Adil I.
المصدر: Cancer Metastasis Through the Lymphovascular System ; page 709-718 ; ISBN 9783030930837 9783030930844